Poly ADP ribose polymerase (PARP) for the treatment of BRCA-mutated advanced ovarian cancer

被引：0
|
作者：
Yunokawa, Mayu [1 ]
机构：
[1] JFCR, Canc Inst Hosp, Gynecol Oncol & Med Oncol Dept, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz336.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MS3 - 4
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [21] Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
    Boussios, Stergios
    Karihtala, Peeter
    Moschetta, Michele
    Karathanasi, Afroditi
    Sadauskaite, Agne
    Rassy, Elie
    Pavlidis, Nicholas
    DIAGNOSTICS, 2019, 9 (03)
  • [22] Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients
    Sivakumaran, Tharani
    Krasovitsky, Michael
    Freimund, Alison
    Lee, Yeh Chen
    Webber, Kate
    So, Jane
    Norris, Christie
    Friedlander, Michael
    Mileshkin, Linda
    Au-Yeung, George
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (07) : 906 - 912
  • [23] Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2-mutated, advanced ovarian and/or locally advanced or metastatic breast cancer.
    Drew, Y.
    Ledermann, J. A.
    Jones, A.
    Hall, G.
    Jayson, G. C.
    Highley, M.
    Rea, D.
    Glasspool, R. M.
    Halford, S. E. R.
    Crosswell, G.
    Colebrook, S.
    Boddy, A. V.
    Curtin, N. J.
    Plummer, E. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Progress in BRCA-Mutated Ovarian Cancer
    Spriggs, David R.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26): : 2567 - 2568
  • [25] Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma
    Graybill, Whitney S.
    Pothuri, Bhavana
    Chase, Dana M.
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (01) : 11 - 15
  • [26] Poly(Adenosine Diphosphate Ribose) Polymerase (PARP) Inhibitors in the Treatment of Advanced Ovarian Cancer: A Narrative Review
    Dewani, Deepika
    Jaiswal, Arpita
    Karwade, Pravin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [27] Expression of poly(ADP-ribose) polymerase (PARP) in ovarian serous carcinoma
    Brustmann, H
    MODERN PATHOLOGY, 2006, 19 : 173A - 173A
  • [28] Expression of poly(ADP-ribose) polymerase (PARP) in ovarian serous carcinoma
    Brustmann, H
    LABORATORY INVESTIGATION, 2006, 86 : 173A - 173A
  • [29] PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
    Taylor, Amelia M.
    Chan, David Lok Hang
    Tio, Martin
    Patil, Sujata M.
    Traina, Tiffany A.
    Robson, Mark E.
    Khasraw, Mustafa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [30] COST COMPARISON OF ADVERSE EVENT MANAGEMENT WITH POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS (PARPI) IN THE MAINTENANCE TREATMENT OF ADVANCED OVARIAN CANCER
    Hettle, R.
    McLaurin, K.
    Mihai, A.
    Poeton, A.
    Muston, D.
    Lopez-Acevedo, M.
    Maguire, P.
    Wynne, T.
    VALUE IN HEALTH, 2020, 23 : S42 - S42
12345